Peroxide Ceiling Differences That Stall Whitening Imports

Whitening Import Peroxide Limits: The Concentration Thresholds That Define Your Regulatory Path

Before a purchase order is placed, before a label is designed, before a shipment is booked — the hydrogen peroxide concentration in a whitening product determines everything that follows. Whitening import peroxide limits are not a post-production detail. They define which regulatory pathway applies, which documentation stack is required, and whether a product can legally enter a market at all. Getting this wrong after production starts is expensive. Getting it right before production starts is straightforward.

This article maps the exact concentration thresholds that trigger different regulatory pathways in the United States and the European Union, so importers know — before they order — precisely which compliance requirements apply to their product.

US Regulatory Framework: Where OTC Ends and Professional Use Begins

In the United States, the FDA regulates tooth-whitening products primarily through the OTC drug monograph system. Any product formulated with hydrogen peroxide or carbamide peroxide that makes a whitening claim is treated as an OTC drug — not a cosmetic. That classification carries specific manufacturing, labeling, and testing obligations.

The OTC monograph framework does not set a single hard peroxide ceiling the way the EU does. Instead, it requires that any formulation sold as an OTC drug meet the conditions of the applicable monograph: active ingredient identity, concentration range, and labeling requirements. Products that fall outside monograph conditions require a New Drug Application (NDA) — a substantially more burdensome pathway.

A whitening gel formulated for professional in-office use at concentrations such as 25–35% hydrogen peroxide is not an OTC product. It is a professional-use product, and its import classification, labeling, and distribution model must reflect that. A 2026 umbrella review of systematic reviews found that moderate hydrogen peroxide concentrations of approximately 25–35% can deliver whitening results comparable to higher concentrations while reducing the frequency and severity of tooth sensitivity [4]. That finding matters for both clinical positioning and regulatory classification: there is no compliance benefit to formulating above the professional-use threshold if the clinical outcome is equivalent.

Carbamide peroxide adds a layer of complexity that importers routinely underestimate. A 2024 study in the Journal of Restorative Dentistry and Endodontics found limited evidence that 37% carbamide peroxide may achieve whitening comparable to 35% hydrogen peroxide after multiple applications, with less bleaching sensitivity [2]. Regulators on both sides of the Atlantic assess effective peroxide release — not just the labeled ingredient. A product labeled as carbamide peroxide is evaluated on its hydrogen peroxide equivalent at the point of contact with tissue, not on its carbamide concentration alone.

EU Whitening Import Peroxide Limits: The Three Statutory Tiers

The European Union draws a hard, statutory line. Under EU Cosmetics Regulation (EC) No 1223/2009, and confirmed by the European Commission's Scientific Committee on Consumer Safety (SCCS), products containing up to 0.1% hydrogen peroxide may be sold directly to consumers as cosmetics [1]. Above that threshold, the regulatory pathway changes fundamentally — and so does the documentation stack.

Products containing between 0.1% and 6% hydrogen peroxide — or the equivalent released from other compounds — require dentist involvement for the first use in each treatment cycle. These products must be supplied to dental practitioners only. The SCCS has confirmed that risks increase with both concentration and application frequency [1]. A whitening strip or gel formulated at 3% hydrogen peroxide cannot be placed on a pharmacy shelf or sold direct-to-consumer in the EU without violating the regulation, regardless of how it is labeled or packaged.

Above 6% hydrogen peroxide, the product exits the EU Cosmetics Regulation entirely. At that concentration, the product must be assessed under the EU Medical Device Regulation (MDR) or another applicable framework — a pathway with substantially higher clinical evidence requirements, notified body involvement, and longer market access timelines. For importers using the EU's Cosmetic Product Notification Portal (CPNP), a product at 7% hydrogen peroxide cannot be CPNP-filed at all. It requires a different regulatory strategy before a single unit enters the EU.

Documentation Architecture by Concentration Tier

The gap between a 0.1% consumer cosmetic and a 6% professional dental product is not just a formulation difference — it is a documentation architecture difference. The table below maps core filing requirements by concentration tier across both markets.

H₂O₂ Equivalent	EU Pathway	US Pathway	Key Documentation Required
Up to 0.1%	EU Cosmetics Regulation — consumer cosmetic; CPNP notification	Cosmetic (if no drug claim) or OTC drug monograph	CPNP file, Product Information File (PIF), safety assessment, Responsible Person designation, ISO 22716 GMP certificate
0.1% – 6%	EU Cosmetics Regulation — dental professional use only; CPNP notification with restricted distribution	OTC drug monograph or professional-use classification	All above, plus dentist-supply documentation, distribution controls, labeling review confirming professional-use language
Above 6%	Outside EU Cosmetics Regulation — MDR or equivalent framework required	Professional use; NDA or enforcement discretion depending on claim and distribution	Clinical data package, notified body engagement (EU), FDA pre-market engagement (US), ISO 13485 if MDR pathway applies

An importer ordering a single SKU at 3% hydrogen peroxide for dual US–EU distribution must understand that the same product triggers different documentation stacks in each market. A CPNP notification does not satisfy FDA OTC requirements, and an FDA monograph compliance review does not substitute for EU safety assessment obligations.

GMP Evidence Each Market Requires at the Point of Entry

Both markets require Good Manufacturing Practice compliance, but the evidence they expect at the border differs in format and specificity.

For the US, FDA expects OTC drug manufacturers — including foreign suppliers — to comply with 21 CFR Part 211 if the product is classified as an OTC drug. The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) introduced mandatory facility registration and GMP requirements for cosmetics, now being phased in. Importers should request a Certificate of Conformance to GMP and verify that the foreign manufacturing site holds active FDA registration with no open import alerts.

For the EU, the Responsible Person must maintain a Product Information File that includes the manufacturing site's GMP compliance documentation. ISO 22716 is the accepted standard for cosmetic products. For products approaching the medical device pathway, ISO 13485 becomes the relevant benchmark. Request the specific standard certificate — with certificate number and expiry date — not a generic quality assurance statement.

The biological rationale behind these requirements is well-documented. A 2024 systematic review in the International Endodontic Journal found that high-concentration hydrogen peroxide bleaching can produce significant short-term pulpal inflammation or necrosis [3]. A 2025 NIH-indexed review confirmed that higher peroxide concentrations increase risks of sensitivity, enamel changes, soft-tissue irritation, and possible cytotoxicity, while lower concentrations generally require longer treatment but are better tolerated [5]. Regulators on both sides of the Atlantic cite this risk profile as the direct basis for their tiered manufacturing and documentation requirements.

Pre-Shipment Checklist: Concentration-Specific Documents to Confirm Before Departure

Have these documents confirmed — not just requested — before a shipment leaves the country of manufacture.

At or Below 0.1% H₂O₂ — EU Consumer Cosmetic / US Cosmetic

• CPNP notification confirmation (EU)
• Product Information File with safety assessment signed by a qualified assessor (EU)
• Responsible Person designation letter (EU)
• FDA cosmetic facility registration under MoCRA (US)
• Certificate of Analysis for the finished batch
• ISO 22716 GMP certificate from the manufacturing site

Between 0.1% and 6% H₂O₂ — EU Professional Dental Use / US OTC or Professional

• All documents listed in the tier above
• Written distribution restriction documentation confirming dental practitioner supply only (EU)
• Labeling review confirming dentist-supply language and usage instructions (EU)
• OTC monograph compliance review or professional-use classification memo (US)
• FDA foreign manufacturing site registration confirmation (US, if OTC drug-classified)
• Stability and compatibility data specific to the formulation concentration

Above 6% H₂O₂ — EU Outside Cosmetics Regulation / US Professional Use

• Regulatory pathway determination memo from a qualified regulatory consultant
• EU notified body engagement confirmation if MDR pathway applies
• Clinical evidence package summary
• FDA pre-market engagement record or enforcement discretion analysis (US)
• ISO 13485 certificate if medical device classification is pursued (EU)

How to Brief a Supplier on Peroxide Limits Before Production Starts

A supplier briefing on whitening import peroxide limits belongs at the formulation stage — not after samples are approved. The briefing needs to be specific enough that the supplier's regulatory team, not just their sales contact, can confirm compliance in writing.

Start with the destination market and the intended distribution channel. A 3% hydrogen peroxide gel destined for EU dental clinics carries different documentation requirements than the same formulation destined for US retail. The supplier needs both pieces of information to advise correctly on labeling, packaging, and batch documentation.

Request written confirmation of the following before approving any formulation:

1. The exact hydrogen peroxide equivalent concentration of the finished product, including peroxide released from carbamide peroxide or other precursor compounds
2. The GMP standard the manufacturing site is certified to, with certificate number and expiry date
3. Whether the site holds active FDA registration and any history of import alerts or warning letters
4. The safety assessment methodology used, and whether the assessor meets EU Cosmetics Regulation qualification requirements
5. Confirmation of which regulatory pathway the supplier has experience supporting — CPNP notification, OTC monograph, or MDR — with documentation of prior successful market entries

Suppliers who cannot answer these questions in writing before production starts represent a compliance risk, regardless of price or lead time. A private-label formulation co-developed to threshold-specific documentation standards is the only reliable foundation for a scalable import program — whether the destination is a dental clinic network, a premium pharmacy chain, or a DTC wellness brand.

References

• [1] European Commission Scientific Committee on Consumer Safety. Tooth Whiteners and Oral Hygiene Products Containing Hydrogen Peroxide. ec.europa.eu
• [2] Journal of Restorative Dentistry and Endodontics. Can Carbamide Peroxide Be as Effective as Hydrogen Peroxide for In-Office Tooth Bleaching? (2024). rde.ac
• [3] International Endodontic Journal. Influence of Dental Bleaching on the Pulp Tissue: A Systematic Review. (2024). onlinelibrary.wiley.com
• [4] Springer Nature. In-Office Tooth Bleaching Protocols: An Umbrella Review of Systematic Reviews. (2026). link.springer.com
• [5] National Institutes of Health / PubMed Central. Tooth-Whitening Agents and Polymer-Based Carriers. (2025). Note: The source URL provided was incomplete. Readers should locate this review directly via PubMed Central using the title above before citing.

Disclaimer

This article is for general informational purposes only and does not constitute sourcing, legal, or regulatory advice. Always conduct your own due diligence and consult qualified legal or compliance professionals before making purchasing or compliance decisions. WhiteningBright makes no warranties as to the completeness or accuracy of the information, and any reliance is at your own risk.